Gewählte Publikation:
Hausegger, KA; Fueger, GF; Ebner, F; Urban, C.
Indications for MIBG scintigraphy in the diagnosis of neuroblastoma
NUKLEARMED. 1989; 28(1): 34-40.
Doi: 10.1055/s-0038-1629468
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Ebner Franz
-
Urban Ernst-Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The significance and indications of MIBG scintigraphy are critically assessed. The results are compared with the results of whole-body bone scintigraphy, computed tomography (CT) and magnetic resonance tomography (MRT), and are related to values of catecholamine metabolites in 24-h urines. In our patients (10 histologically proven cases) MIBG scintigraphy turned out to be most useful in tumor follow-up. In contrast, the significance was much lower in primary tumor diagnosis and tumor staging as the exact primary diagnosis was established by other means such as CT, MRT, MDP whole-body scan, urine chemistry and bone marrow biopsy in all cases. MIBG scintigraphy in diagnostic imaging of neuroblastoma is an additive diagnostic tool and is called for in (1) tumour follow-up (progress, recurrencies, metastases); (2) primary diagnosis if the primary tumour has not been localized by means of CT or MRT; and (3) tumour staging to differentiate stage IV disease from lower stages as long as stage IV disease has not been established by bone-marrow biopsy or MDP whole-body scan.
- Find related publications in this database (using NLM MeSH Indexing)
-
3-Iodobenzylguanidine -
-
Adolescent -
-
Adult -
-
Bone Neoplasms - radionuclide imaging
-
Child - radionuclide imaging
-
Child, Preschool - radionuclide imaging
-
Female - radionuclide imaging
-
Ganglioneuroma - radionuclide imaging
-
Humans - radionuclide imaging
-
Infant - radionuclide imaging
-
Iodine Radioisotopes - diagnostic use
-
Iodobenzenes - diagnostic use
-
Male - diagnostic use
-
Neuroblastoma - radionuclide imaging